3rd Quarter - Report

ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- The Federal, Food, Drug and Cosmetic Act - The Food and Drug Administration Safety and Innovation Act (FDASIA) - Bayh-Dole Act/ march in authority

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —
VINCENT A. ROBERTI, SR. —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

- CMMI Part B Drug Payment Demonstration Program - General reimbursement issues - H.R. 1178- Ensuring Equal Access to Treatments Act- all provisions

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —
VINCENT A. ROBERTI, SR. —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1178 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.